期刊文献+

脑钠肽在心力衰竭诊治中的研究进展 被引量:23

下载PDF
导出
作者 白梅
出处 《中国心血管病研究》 CAS 2005年第4期312-314,共3页 Chinese Journal of Cardiovascular Research
  • 相关文献

参考文献13

  • 1[1]Maisel AS, Koon J, Krishnaswamy P, et al. Utility of Bnatriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J,2001,141(3): 367-374
  • 2[2]Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol, 2001.,37:379-385
  • 3[3]McDonagh TA, Robb SD, Murdoch DR, et al.Biochemical detection of left -ventricular systolic dysfunction. Lancet, 1998, 351(9095): 9-13
  • 4[4]Groenning BA, Nilsson JC, Sonderguard L,,et al.Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail, 2001, 3(6):699-708
  • 5[5]Sagnella GA. Mearement and significance of circulating natriuretic peptide in cardiovascular disease. Clin Sci,1998, 95:519-529
  • 6[6]Yamaguchi H, Yoshida J, Yamamoto K, et al. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol, 2004, 43:55-60
  • 7[7]Lubien E, DeMaria A, Krishnaswany P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction:comparison with Doppler velocity recordings. Circulation,2002, 105(5): 595-601
  • 8[8]Nicholls MG, Lainchbury JG, Richards AM, et al. Brain natriuretic peptide-guided therapy for heart failure.Nicholls MG, Lainchbury JG, Richards AM, Troughton RW, Yandle TG. Ann Med, 2001, 33(6): 422-427
  • 9[9]Murdoch DR, McDonagh TA, Byrne J, et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration:randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J, 1999, 138(6Pt1): 1126-1132
  • 10[10]Richards AM, Doughty R, Nicholls MG, et al.Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. Circulation, 1999, 99(6): 786-792

同被引文献201

引证文献23

二级引证文献174

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部